|
|
Developmental underpinnings of substantia nigra vulnerability |
| 5R01NS119690-02 |
|
NINDS |
2022 |
|
|
Pathomechanisms of SCN3A-related neurodevelopmental disorder |
| 5R01NS119977-02 |
|
NINDS |
2022 |
|
|
Combinatorial function of Foxp1/2/4 in Purkinje cell diversification and cerebellar development |
| 5R01NS120556-02 |
|
NINDS |
2022 |
|
|
Cellular and molecular mechanisms underlying DDX3X syndrome |
| 5R01NS120667-02 |
|
NINDS |
2022 |
|
|
Harnessing post-translational regulation of SHANK3 as a boosting strategy for Phelan-McDermid syndrome |
| 5R01NS120980-02 |
|
NINDS |
2022 |
|
|
Cerebellar and Basal Ganglia Markers Underlie Neuromotor Impairments in Adults with Autism Spectrum Disorder (ASD) |
| 5R01NS121120-02 |
|
NINDS |
2022 |
|
|
The Pathophysiological Role of Cerebellar Glia in Rett Syndrome |
| 5R01NS121542-02 |
|
NINDS |
2022 |
|
|
Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse Chimeras |
| 5R01NS122108-02 |
|
NINDS |
2022 |
|
|
Novel pathogenic mechanism of HIV-associated CNS neurological disorders |
| 5R01NS124477-02 |
|
NINDS |
2022 |
|
|
STRUCTURAL VARIATION IN NEUROLOGICAL DISEASE |
| 5R35NS105078-05 |
|
NINDS |
2022 |